These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. A clinical and pathological study of myeloneuropathy following abdominal disorders. Tatetsu S, Miyakawa T, Fujita E, Takaki M, Harada M. Folia Psychiatr Neurol Jpn; 1971; 25(4):225-33. PubMed ID: 5172641 [No Abstract] [Full Text] [Related]
6. Subacute myelo-optico-neuropathy (SMON) in Japan. With special reference to the autopsy cases. Egashira Y, Matsuyama H. Acta Pathol Jpn; 1982; 32 Suppl 1():101-16. PubMed ID: 6316716 [Abstract] [Full Text] [Related]
7. [Abdominal symptoms of subacute myelo-optico-neuropathy (SMON)--with special reference to relationship between chinoform and ileus-like symptoms]. Inoue N, Tamura K, Kuroiwa Y, Ysukochi T, Naritomi T. Rinsho Shinkeigaku; 1973 Sep; 13(9):537-42. PubMed ID: 4796521 [No Abstract] [Full Text] [Related]
8. A patho-anatomical study of the central and peripheral nervous system in diabetes of early onset and long duration. Olsson Y, Säve-Söderbergh J, Sourander P, Angervall L. Pathol Eur; 1968 Sep; 3(1):62-79. PubMed ID: 5670420 [No Abstract] [Full Text] [Related]
12. [6 cases of so-called subacute myelo-optico-neuropathy with abdominal symptoms in a ward of a tuberculosis sanatorium]. Nakamura Y, Ogata J, Watanabe T, Kumagai T. Shinkei Kenkyu No Shimpo; 1971 Jan 18; 15(4):1019-31. PubMed ID: 5168624 [No Abstract] [Full Text] [Related]
13. [Pathology of subacute myelo-optico-neuropathy]. Matsuyama H, Ogawa Y, Nakamura S, Hata J. Saishin Igaku; 1969 Dec 18; 24(12):2469-78. PubMed ID: 5363407 [No Abstract] [Full Text] [Related]
14. [Quantitative histological change of myelinated nerve fibers and its significance. (II) In SMON(subacute-myelo-optico-neuropathy)]. Matsuoka Y, Mukoyama M, Takayanagi T, Sobue I. Rinsho Shinkeigaku; 1977 May 18; 17(5):310-5. PubMed ID: 560277 [No Abstract] [Full Text] [Related]
15. [Peripheral nerve diseases in SMON. 3. Comparison of teased nerve fibers taken from patients with SMON and from normal controls]. Tsukagoshi H, Togi H. Rinsho Shinkeigaku; 1972 Aug 18; 12(8):372-80. PubMed ID: 4674288 [No Abstract] [Full Text] [Related]
16. [Neuropathology of longstanding subacute myelo-optico-neuropathy (SMON): an autopsy case of SMON with duration of 28 years]. Konno H, Takase S, Fukui T. No To Shinkei; 2001 Sep 18; 53(9):875-80. PubMed ID: 11596484 [Abstract] [Full Text] [Related]
17. [Aetiological and clinical study on subacute myelo-optico-neuropathy (SMON) (author's transl)]. Tsubaki T. Nihon Naika Gakkai Zasshi; 1974 Jan 10; 63(1):1-17. PubMed ID: 4856733 [No Abstract] [Full Text] [Related]
18. Subacute myelo-optico-neuropathy (SMON)--neurotoxicity of clioquinols. Selby G. Proc Aust Assoc Neurol; 1973 Jan 10; 9():23-30. PubMed ID: 4268933 [No Abstract] [Full Text] [Related]